David C Dalgarno Selected Research

Therapeutics

1/2023	Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancer.
1/2016	Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
11/2009	AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.
8/2009	9-(Arenethenyl)purines as dual Src/Abl kinase inhibitors targeting the inactive conformation: design, synthesis, and biological evaluation.
9/2006	Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.
10/2004	Differences in F36VMpl-based in vivo selection among large animal models.
9/2003	Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C Dalgarno Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 09/2003
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011 - 06/2006
5	Bone Diseases (Bone Disease) 10/2006 - 01/2002
4	Osteoporosis 10/2006 - 09/2003
3	Bone Resorption 10/2006 - 09/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Carcinogenesis 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 09/2006
1	Carcinoma (Carcinomatosis) 09/2006
1	Pathologic Processes 10/2004
1	Neoplasm Metastasis (Metastasis) 09/2003

Drug/Important Bio-Agent (IBA)

6	src-Family KinasesIBA 10/2006 - 01/2002
4	EnzymesIBA 01/2016 - 09/2003
4	Phosphotransferases (Kinase)IBA 06/2010 - 01/2002
3	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 06/2006
2	Adenosine Triphosphate (ATP)IBA 02/2013 - 09/2003
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010 - 09/2006
2	Diphosphonates (Bisphosphonates)IBA 10/2006 - 09/2003
1	mobocertinibIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Phosphorylcholine (Phosphocholine)IBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Choline KinaseIBA 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016
1	Lactate Dehydrogenase 5IBA 02/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2013
1	ponatinibIBA 11/2009
1	nilotinib FDA Link 11/2009
1	Dasatinib (BMS 354825)FDA Link 11/2009
1	AP 24163IBA 08/2009
1	Docetaxel (Taxotere)FDA Link 09/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2006
1	AP23846IBA 09/2006
1	AP22408IBA 09/2003
1	LigandsIBA 09/2003
1	PurinesIBA 09/2003
1	Zoledronic Acid (Zometa)FDA Link 09/2003
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2003
1	AP23236IBA 09/2003
1	Protein Kinases (Protein Kinase)IBA 01/2002

Therapy/Procedure

7	Therapeutics 01/2023 - 09/2003
2	Oral Administration 01/2023 - 08/2009